AltStreet
EDGAR Verified
Primary Source · SEC.gov

EquityZen Growth Technology Fund LLC - Series 1748

CIK 0001980507Single-Deal SPV2023 vintage506(b), 3(c)(1)

Raised

$228K

Investors

8

Min Invest

$3,084

AltStreet Analysis

·

Generated from EDGAR primary sources

EquityZen Growth Technology Fund LLC - Series 1748 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett. The entity raised $228K from 8 investors with a $3K minimum investment, relying on Rule 506(b) and Section 3(c)(1) exemptions. It is part of EquityZen's platform of nearly 1,900 pre-IPO secondary market vehicles.

This pre-IPO fund follows the standard EquityZen structure: a series-based pooled vehicle under 3(c)(1) exemption with 506(b) private placement rules. The $3K minimum investment represents the platform's characteristic low-barrier access model for retail participation in late-stage private company secondaries, contrasting with typical institutional pre-IPO vehicles that require six-figure minimums.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001980507
Entity NameEquityZen Growth Technology Fund LLC - Series 1748
Exemption506(b), 3(c)(1)
First Sale Date—
Filing DateAugust 14, 2023
Accession Number0001980507-23-000001
Total Amount Sold$228K
Total Investors8
Minimum Investment$3,084
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

EquityZen Advisors LLC

Executive Officer, Director · New York, NY

Philip Haslett

Executive Officer, Director · New York, NY

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.